Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
03 2023
Historique:
revised: 29 12 2022
received: 07 11 2022
accepted: 22 01 2023
pubmed: 6 2 2023
medline: 15 3 2023
entrez: 5 2 2023
Statut: ppublish

Résumé

The impact of occlusion length on the procedural techniques and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study. We examined the clinical and angiographic characteristics and procedural outcomes of 10,335 CTO PCIs at 42 US and non-US centers between 2012 and 2022. The cohort was divided into two groups based on lesion length (≥20 mm vs. <20 mm). Long lesions were present in 7208 (70%) patients. Comorbidities were more common in patients with long CTOs. Compared with short lesions, long lesions had higher J-CTO score (2.8 ± 1.1 vs. 1.3 ± 1; p < 0.001) and retrograde wiring was more often the initial (15.5% vs. 4.0%; p < 0.001) and successful (22.8% vs. 8.2%; p < 0.001) crossing strategy. Long lesions were more likely to require longer procedure (123 vs. 91 min; p < 0.001) and fluoroscopy (47.1 vs. 32.2 min; p < 0.001) time, larger contrast volume (218 vs. 200 mL; p < 0.001) and higher air kerma radiation dose (2.4 vs. 1.7 Gy; p < 0.001). After adjusting for potential confounders, long lesions were associated with lower technical success (odds ratio [OR]: 0.91 per 10 mm increase; 95% confidence interval [CI]: 0.88, 0.94) and higher major adverse cardiovascular events (MACE) (OR: 1.08 per 10 mm increase; 95% CI: 1.02, 1.15). CTO PCI of long occlusions is independently associated with lower rates of technical success and higher rates of in-hospital MACE.

Sections du résumé

BACKGROUND
The impact of occlusion length on the procedural techniques and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study.
METHODS
We examined the clinical and angiographic characteristics and procedural outcomes of 10,335 CTO PCIs at 42 US and non-US centers between 2012 and 2022. The cohort was divided into two groups based on lesion length (≥20 mm vs. <20 mm).
RESULTS
Long lesions were present in 7208 (70%) patients. Comorbidities were more common in patients with long CTOs. Compared with short lesions, long lesions had higher J-CTO score (2.8 ± 1.1 vs. 1.3 ± 1; p < 0.001) and retrograde wiring was more often the initial (15.5% vs. 4.0%; p < 0.001) and successful (22.8% vs. 8.2%; p < 0.001) crossing strategy. Long lesions were more likely to require longer procedure (123 vs. 91 min; p < 0.001) and fluoroscopy (47.1 vs. 32.2 min; p < 0.001) time, larger contrast volume (218 vs. 200 mL; p < 0.001) and higher air kerma radiation dose (2.4 vs. 1.7 Gy; p < 0.001). After adjusting for potential confounders, long lesions were associated with lower technical success (odds ratio [OR]: 0.91 per 10 mm increase; 95% confidence interval [CI]: 0.88, 0.94) and higher major adverse cardiovascular events (MACE) (OR: 1.08 per 10 mm increase; 95% CI: 1.02, 1.15).
CONCLUSIONS
CTO PCI of long occlusions is independently associated with lower rates of technical success and higher rates of in-hospital MACE.

Identifiants

pubmed: 36740236
doi: 10.1002/ccd.30581
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

747-755

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 Minutes. JACC: Cardiovasc Intervent. 2011;4:213-221.
Alessandrino G, Chevalier B, Lefèvre T, et al. A clinical and angiographic scoring system to predict the probability of successful first-attempt percutaneous coronary intervention in patients with total chronic coronary occlusion. JACC: Cardiovasc Intervent. 2015;8:1540-1548.
Maeremans J, Spratt JC, Knaapen P, et al. Towards a contemporary, comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: the RECHARGE score. Catheter Cardiovasc Interv. 2018;91:192-202.
Szijgyarto Z, Rampat R, Werner GS, et al. Derivation and validation of a chronic total coronary occlusion intervention procedural success score from the 20,000-Patient EuroCTO registry. JACC: Cardiovasc Intervent. 2019;12:335-342.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377-381.
Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020-2035.
Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions. JACC: Cardiovasc Intervent. 2016;9:1-9.
Simsek B, Kostantinis S, Karacsonyi J, et al. Predicting periprocedural complications in chronic total occlusion percutaneous coronary intervention. JACC: Cardiovasc Intervent. 2022;15:1413-1422.
Fujino A, Otsuji S, Hasegawa K, et al. Accuracy of J-CTO score derived from computed tomography versus angiography to predict successful percutaneous coronary intervention. JACC. Cardiovasc Imaging. 2018;11:209-217.
Latif A, Ahsan MJ, Kabach A, et al. Impact of diabetes mellitus on outcomes of percutaneous coronary intervention in chronic total occlusions: a systematic review and meta-analysis. Cardiovasc Revascular Med. 2022;37:68-75.
Simsek B, Kostantinis S, Karacsonyi J, et al. Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction. Catheter Cardiovasc Interv. 2022;99:1059-1064.
Nikolakopoulos I, Choi JW, Khatri JJ, et al. Follow-up outcomes after chronic total occlusion percutaneous coronary intervention in patients with and without prior coronary artery bypass graft surgery: insights from the PROGRESS-CTO registry. J Invasive Cardiol. 2020;32:315-320.
Xenogiannis I, Gkargkoulas F, Karmpaliotis D, et al. The impact of peripheral artery disease in chronic total occlusion percutaneous coronary intervention (insights from PROGRESS-CTO registry). Angiology. 2020;71:274-280.
Kostantinis S, Simsek B, Karacsonyi J, et al. TCT-117 impact of proximal cap ambiguity on the outcomes of chronic total occlusion intervention: insights from the PROGRESS-CTO registry. J Am Coll Cardiol. 2022;80:B48-B49.
Karacsonyi J, Karmpaliotis D, Alaswad K, et al. Impact of calcium on chronic total occlusion percutaneous coronary interventions. Am J Cardiol. 2017;120:40-46.
Karacsonyi J, Karmpaliotis D, Alaswad K, et al. The impact of proximal vessel tortuosity on the outcomes of chronic total occlusion percutaneous coronary intervention: insights from a contemporary multicenter registry. J Invasive Cardiol. 2017;29:264-270.
Wu EB, Brilakis ES, Mashayekhi K, et al. Global chronic total occlusion crossing algorithm. JACC. 2021;78:840-853.
Danek BA, Karatasakis A, Karmpaliotis D, et al. Development and validation of a scoring system for predicting periprocedural complications during percutaneous coronary interventions of chronic total occlusions: the prospective global registry for the study of chronic total occlusion intervention (PROGRESS CTO) complications score. J Am Heart Assoc. 2016;5:e004272.
Hirai T, Grantham JA, Sapontis J, et al. Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score. Catheter Cardiovasc Interv. 2022;99:280-285.
Ahn J, Rha SW, Choi B, et al. Impact of chronic total occlusion lesion length on six-month angiographic and 2-year clinical outcomes. PLoS One. 2018;13:e0198571.
Tian T, Guan C, Gao L, et al. Prognostic significance of occlusion length in recanalized chronic total occlusion lesion: a retrospective cohort study with 5-year follow-up. BMJ Open. 2020;10:e038302.

Auteurs

Athanasios Rempakos (A)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Bahadir Simsek (B)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Spyridon Kostantinis (S)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Judit Karacsonyi (J)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

James W Choi (JW)

Department of Cardiology, Texas Health Presbyterian Hospital, Dallas, TX, USA.

Paul Poommipanit (P)

Section of Cardiology, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.

Jaikirshan J Khatri (JJ)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

Wissam Jaber (W)

Division of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.

Stephane Rinfret (S)

Division of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.

William Nicholson (W)

Division of Cardiology, Emory University Hospital Midtown, Atlanta, Georgia, USA.

Sevket Gorgulu (S)

Department of Cardiology, Biruni University Medical School, Istanbul, Turkey.

Farouc A Jaffer (FA)

Cardiovascular Research Center and Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.

Raj Chandwaney (R)

Department of Invasive Cardiology, Oklahoma Heart Institute, Tulsa, Oklahoma, USA.

Michael Koutouzis (M)

Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece.

Ioannis Tsiafoutis (I)

Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece.

Khaldoon Alaswad (K)

Division of Cardiology, Henry Ford Hospital, Detroit, Michigan, USA.

Oleg Krestyaninov (O)

Department of Invasive Cardiology, Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.

Dmitrii Khelimskii (D)

Department of Invasive Cardiology, Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.

Dimitrios Karmpaliotis (D)

Gagnon Cardiovascular Institute, Morristown Medical Center, New Jersey, USA.

Barry F Uretsky (BF)

Department of Cardiology, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA.

Mitul P Patel (MP)

Division of Cardiovascular Medicine, UCSD Medical Center, La Jolla, California, USA.

Ehtisham Mahmud (E)

Division of Cardiovascular Medicine, UCSD Medical Center, La Jolla, California, USA.

Srinivasa Potluri (S)

Department of Cardiac Catheterization, The Heart Hospital Baylor Plano, Plano, Texas, USA.

Bavana V Rangan (BV)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Olga C Mastrodemos (OC)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Salman Allana (S)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Yader Sandoval (Y)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Nicholas M Burke (NM)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Emmanouil S Brilakis (ES)

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH